ACUTE LYMPHOCYTIC LEUKEMIA OPTIONS

Postexposure prophylaxis (PEP) has long been demonstrated to lessen the risk of HIV infection when administered quickly soon after publicity. Pointers are available for occupational and nonoccupational exposures.Biktarvy - bictegravir/tenofovir AF/emtricitabine — just for patients with pretreatment approximated CrCl ≥30 mL/minChemotherapy is